A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
Clinical trial NCT03136991 · COMPLETED
Trial details
- NCT number
- NCT03136991
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2017-11-22
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.